Compass Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Compass Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Compass Therapeutics Inc
Rating: 1.88558325
Author: Trendlyne DVM scores

about

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its...

3.49 0.00 (0.00%)

174.80% Gain from 52W Low

702.5K

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Compass Therapeutics Inc is on 09 Sep 2025 for the purpose of Morgan Stanley 23(rd) Annual Global Healthcare Conference See details